Explore the exciting world of NovoCure (NVCR 0.33%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
*Stock prices used were the prices of Jan. 29, 2025. The video was published on March 4, 2025.
S&P 500
5,944.20
-0.3%
-19.40
DJI
42,701.21
-0.2%
-90.86
NASDAQ
$19,152.23
-0.3%
-$63.23
Bitcoin
106,204.00
+0.8%
+803.59
AAPL
$206.73
-1.0%
-$2.05
AMZN
$204.10
-1.0%
-$2.06
GOOG
$166.91
-0.6%
-$0.96
META
$636.63
-0.6%
-$3.80
MSFT
$456.61
-0.5%
-$2.26
NVDA
$134.20
-1.0%
-$1.37
TSLA
$352.78
+3.1%
+$10.69
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Prediction: Novocure (NVCR) Will Beat the Market. Here's Why
By Motley Fool YouTube
–
Mar 4, 2025 at 7:00PM
NASDAQ: NVCR
NovoCure
Market Cap
$2B
Today's Change
(0.33%) $0.06
Current Price
$18.02
Price as of May 20, 2025, 2:04 p.m. ET
Karl Thiel has positions in NovoCure. Keith Speights has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends NovoCure. The Motley Fool has a disclosure policy.
Stocks Mentioned
NovoCure
NVCR
$18.02
(0.33%)
$0.06
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Why NovoCure Stock Skyrocketed This Week
Why NovoCure Stock Leaped 4% Higher Today
NovoCure Surpasses Q1 Expectations
Why NovoCure Stock Was Withering on Wednesday
NovoCure (NVCR) Q4 2024 Earnings Call Transcript
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.